Free fatty acids are involved in the inverse relationship between hormone-sensitive lipase (HSL) activity and expression in adipose tissue after high-fat feeding or β3-adrenergic stimulation

Obesity Research

Volumn 8, Issue 3, 2000, Pages 255-261

  Berraondo, Beatriz ^a   Martínez, J Alfredo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Cafeteria diet; Fatty acids; Hormone sensitive lipase; Obesity; 3 adrenergic agonists

Indexed keywords

ANIMALIA; CAFETERIA;

BENZYL ALCOHOL DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLESTEROL ESTERASE; DNA; FATTY ACID; MESSENGER RNA; PRIMER DNA; TRECADRINE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BLOOD; BODY COMPOSITION; BODY WEIGHT; CHEMISTRY; DENSITOMETRY; ENZYMOLOGY; FAT INTAKE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; LIPOLYSIS; METABOLISM; NONPARAMETRIC TEST; PHYSIOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

ADIPOSE TISSUE; ADRENERGIC BETA-AGONISTS; ANIMALS; BENZYL ALCOHOLS; BODY COMPOSITION; BODY WEIGHT; CHOLESTEROL ESTERASE; DENSITOMETRY; DIETARY FATS; DNA; DNA PRIMERS; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIPOLYSIS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 0034183503     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2000.30     Document Type: Article

References (35)

1. Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med. 1997;337:396-407.
2. Weiser M, Frishman WH, Michaelson D, Abdeen MA. The pharmacologic approach to the treatment of obesity. J Clin Pharmacol. 1997;37:453-73.
3. National Institutes of Health. Clinical guidelines of the identification, evaluation, and treatment of overweight and obesity in adults. Obes Res. 1998;6:51S-209S.
4. Rippe JM. The case for medical management of obesity: a call for increased physician involvement. Obes Res. 1998;6: 23S-33S.
5. 3-adrenoceptors. J Clin Pharmacol. 1996;42:219-30.
6. 3-adrenergic receptor. Annu Rev Pharmacol Toxicol. 1997;37:421-50.
7. Frayn KN, Coppack SW, Fielding BA, Humphreys SM. Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: implications for the control of fat storage and fat mobilization. Adv Enzyme Regul. 1995;35:163-78.
8. Langin D, Holm C, Lafontan M. Adipocyte hormone-sensitive lipase: a major regulator of lipid metabolism. Proc Nutr Soc. 1996;55:93-109.
9. Laurell H, Grober J, Stenson Holst L, Holm C, Mohrenweiser HW, Langin D. The hormone-sensitive lipase (LIFE) gene located on chromosome 19q13.1→13.2 is not duplicated on 19q13.3. Int J Obes. 1995;19:590-2.
10. Grober J, Laurell H, Biaise R, et al. Characterization of the promoter of human adipocyte hormone-sensitive lipase. Biochem J. 1997;328:453-61.
11. Laurell H, Grober J, Vindis C, et al. Species-specific alternative splicing generates a catalytically inactive form of human hormone-sensitive lipase. Biochem J. 1997;328:137-43.
12. Langin D, Laurell H, Stenson Hoist L, Belfrage P, Holm C. Gene organization and primary structure of human hormone-sensitive lipase: possible significance of a sequence homology with a lipase of Moraxella TA144, an antarctic bacterium. Proc Natl Acad Sci USA. 1993;90:4897-901.
13. Holm C, Langin D, Manganiello VC, Belfrage P, Degerman E. Regulation of hormone-sensitive lipase activity in adipose tissue. Methods Enzymol. 1997;286:45-67.
14. Barrionuevo M, Milagro FI, Cenarruzabeitia E, Martinez JA. Potential anti-diabetic applications of a new molecule with affinity for β3-adrenoceptors. Life Sci. 1996; 59:141-6.
15. 3-adrenergic agonist in rats fed on a cafeteria diet. Eat Weight Disord. 1997;2:130-7.
16. Díez-Sampedro A, Milagro FI, Berraondo B, Zulet MA, Martinez JA. Effects of Trecadrine, a β3-adrenergic agonist, on intestinal absorption of D-galactose and disaccharidase activities in three physiopathological models. J Pharm Pharmacol. 1997;49:873-7.
17. Rossetti L, Massillon D, Barzilai N, et al. Short term effects of leptin on hepatic gluconeogenesis and in vitro insulin action. J Biol Chem. 1997;272:27758-63.
18. Shih MF, Taberner PV. Selective activation of brown adipocyte hormone-sensitive lipase and cAMP production in the mouse by β3-adrenoceptor agonists. Biochem Pharmacol. 1995;50:601-8.
19. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C. Hepatology. 1996;23:210-7.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem. 1987;162:156-9.
21. Charon C, Dupoy F, Marie V, Bazin R. Effect of the β-adrenoceptor agonist BRL-35135 on development of obesity in suckling Zucker rats. Am J Physiol. 1995;268:1039-45.
22. Himms-Hagen J, Cui J, Danforth E, et al. Effect of CL-316,243, a thermogenic β3-agonist, on energy balance and brown and white adipose tissues in rats. Am J Physiol. 1994; 266:R1371-R82.
23. Hui DY. Molecular biology of enzymes involved with cholesterol ester hydrolysis in mammalian tissues. Biochim Biophys Acta. 1996;1303:1-14.
24. Arner P. Regulation of lipolysis in fat cells. Diabetes Rev. 1996;4:450-63.
25. Hashimoto K, Nagao Y, Ida K, et al. Improvement of metabolic disorders and visceral fat obesity by the β3-adrenoceptor agonist (R*,R*)-(±)-methyl-4-[2-[2-hydroxy(2,3-chlorophenyl) ethylamino]propyl]phenoxyacetate hydrobromi (BRL 35135) in genetically obese rodents. Biochem Pharmacol. 1996;52:1529-35.
26. Yamamoto H, Takakura S, Yamamoto T, et al. FR149175, a β3-adrenoceptor selective agonist, is a possible therapeutic agent for non-insulin-dependent diabetes mellitus. Jpn J Pharmacol. 1997;74:109-12.
27. Stich V, Harant I, Deglisezinski I, et al. Adipose tissue lipolysis and hormone-sensitive lipase expression during very low calorie diet in obese female identical twins. J Clin Endocrinol Metab. 1997;82:739-44.
28. Liu CY, Liang LC, Chang LC. Differential responses of hormone-sensitive lipase gene to nutritional transition in adipose tissue, liver, and skeletal muscle of pigs. Biochem Mol Biol Int. 1995;36:689-94.
29. Sztalryd C, Kraemer FB. Regulation of hormone-sensitive lipase during fasting. Am J Physiol. 1994;266:E179-E85.
30. Thompson MP, Cooper ST, Parry BR, Tuckey JA. Increased expression of the mRNA for hormone-sensitive lipase in adipose tissue of cancer patients. Biochim Biophys Acta. 1993;1180:236-42.
31. Hellstrom L, Langin D, Reynisdottir S, Dauzats M, Arner P. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives. Diabetologia. 1996;39:921-8.
32. Reynisdottir S, Eriksson M, Angelin B, Arner P. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia. J Clin Invest. 1995;95:2161-9.
33. Sniderman AD, Cianflone K, Summers L, Fielding B, Frayn K. The acylation-stimulating protein pathway and regulation of postprandial metabolism. Proc Nutr Soc. 1997;56: 703-12.
34. Frayn KN, Williams CM, Arner P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin Sci Colch. 1996;90:243-53.
35. Sztalryd C, Kraemer FB. Regulation of hormone-sensitive lipase in streptozotocin-induced diabetic rats. Metabolism. 1995;44:1391-6.